Ribon Therapeutics
www.ribontx.comRibon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors to block the fundamental ability of cancer cells to survive under stress.
Read more
Ribon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors to block the fundamental ability of cancer cells to survive under stress.
Read more
Country
State
Massachusetts
City (Headquarters)
Newton
Industry
Employees
11-50
Founded
2015
Estimated Revenue
$5,000,000 to $10,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President , Translational Sciences
Email ****** @****.comPhone (***) ****-****Vice President Regulatory Affairs
Email ****** @****.comPhone (***) ****-****President and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chief Business Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(9)
Reach decision makers at Ribon Therapeutics
Free credits every month!
Ribon Therapeutics FAQ
Newton, United States
Biotechnology Research
